Tumor-carrying ATGL-deficient mice can resist lipolysis of white adipose tissue, cardiomyocyte apoptosis, and increased proteasome muscle degradation, and maintain normal fat and gastrocnemius muscle mass [37]. This evidence concerns the gene PNPLA2 and neoplasm.